MRI Interventions’ ClearPoint® Neuro Navigation System Utilized for the First Time at Inova Fairfax Hospital
IRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative neuro navigation platforms for performing minimally invasive surgical procedures in the brain, today announced the completion of the first deep brain stimulation (DBS) procedure at the Inova Fairfax Hospital in Falls Church, VA, using the Company’s ClearPoint Neuro Navigation System.
“We have been offering deep brain stimulation for our Parkinson’s Disease patients for over 3 years, but many patients were hesitant about the conventional stereotactic procedure. With ClearPoint, I was able to place the electrode with sub-millimeter accuracy while the patient was under general anesthesia. For a large group of patients who fear the traditional operating room approach, we can now offer an alternative,” said Dr. Mahesh Shenai, Director for Functional and Restorative Neurosurgery at the Inova Neuroscience and Spine Institute.
“By doing the electrode placement portion of the procedure under direct MRI guidance, Inova Fairfax can now offer a highly accurate, comfortable approach to their patients,” said Wendelin Maners, Vice President of Marketing. “We are committed to advancing the ClearPoint system’s proprietary real-time MRI neuro navigation platform into other therapies for which we can positively impact both patient outcomes and comfort.”
The ClearPoint Neuro Navigation System provides the surgeon with real-time MRI views of the patient’s brain anatomy at the time of surgical planning, device alignment, and navigation of the device to target, resulting in improved accuracy and reduced risk of brain shift associated with standard imaging techniques that often utilize static, pre-operative images and require attaching a large, metal stereotactic headframe to the patient.
About MRI Interventions, Inc.
Building on the imaging power of magnetic resonance imaging, or MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the Company’s ability to obtain additional financing; estimates regarding the sufficiency of the Company’s cash resources; future revenues from sales of the Company’s ClearPoint system products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint system products. More detailed information on these and additional factors that could affect the Company's actual results are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2015, and the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2016, both of which have been filed with the Securities and Exchange Commission.
Contact: Wendelin Maners, VP, Marketing MRI Interventions, Inc. 949-900-6833